Dr. Sri Bharathi Yadlapalli, MD

Dr. Yadlapalli practices at IHA Hematology Oncology Oakland in Ann Arbor, Michigan.

Dr. Yadlapalli's NPI, 1295092849, was assigned on April 20, 2012. Dr. Yadlapalli holds Michigan license 4301100485.

Dr. Yadlapalli's primary practice is IHA Hematology Oncology Oakland, at 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 in Washtenaw County. The practice phone is (248) 858-2270.

Dr. Yadlapalli's primary practice is IHA Hematology Oncology Oakland in Ann Arbor, Michigan. Dr. Yadlapalli is also affiliated with Trinity Health Oakland Hospital. The medical group on file is Trinity Health Academic Obstetrics & Gynecology - Pontiac (Trinity Health IHA Medical Group). Dmand AI also links Dr. Yadlapalli to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yadlapalli practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Yadlapalli's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Yadlapalli is licensed in Michigan.

CMS data shows 1,053 Medicare services from Dr. Yadlapalli across 9 procedure codes in 2024, for 272 Medicare patients. Medicare paid $83,868 for them.

CMS counts 272 Medicare patients who saw Dr. Yadlapalli in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yadlapalli's median patient age at 72, with 70% women.

In 2024, Dr. Yadlapalli wrote 605 Medicare Part D claims for 155 patients. 75% of them were for generic drugs. CMS names the drug for 399 of them, across 12 drugs with 11 or more claims each, at $654,388 in total drug cost. In 2023, CMS named 220 claims across 8 drugs.

Dr. Yadlapalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yadlapalli as offering telehealth.

Dmand AI links 4 papers to Dr. Yadlapalli, published from 2022 to 2023. 2022 was the busiest year, with 3. Dr. Yadlapalli has published most often in Cureus. Dr. Yadlapalli's most frequent co-authors are Mirna Sabah Mikhael Yacoub, MD and Ali K. Najar, MD.

CMS Open Payments shows 147 general payments to Dr. Yadlapalli from 32 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 79% of the total. Amgen Inc. paid the most, $556.